Leslie Garrison

916 total citations
23 papers, 696 citations indexed

About

Leslie Garrison is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Leslie Garrison has authored 23 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Leslie Garrison's work include Neutropenia and Cancer Infections (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Neuroblastoma Research and Treatments (4 papers). Leslie Garrison is often cited by papers focused on Neutropenia and Cancer Infections (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Neuroblastoma Research and Treatments (4 papers). Leslie Garrison collaborates with scholars based in United States and Canada. Leslie Garrison's co-authors include James B. Whitmore, Miguel J. Lanz, Jan M. Agosti, Larry Borish, Lori Claussen, Harold S. Nelson, B. F. Fernie, K Midthun, David A. Smith and Cynthia E. Dunbar and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Leslie Garrison

23 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie Garrison United States 11 289 212 146 144 116 23 696
A. E. G. Kr. v. d. Borne Netherlands 13 189 0.7× 203 1.0× 215 1.5× 254 1.8× 82 0.7× 17 603
Michael E. Osband United States 16 321 1.1× 378 1.8× 71 0.5× 105 0.7× 114 1.0× 42 868
Maurizio Caniglia Italy 17 76 0.3× 292 1.4× 389 2.7× 55 0.4× 172 1.5× 58 882
Åke Jakobson Sweden 14 345 1.2× 72 0.3× 72 0.5× 80 0.6× 96 0.8× 29 687
Schwartz Rs United States 12 64 0.2× 321 1.5× 108 0.7× 49 0.3× 123 1.1× 27 835
Marta Cebrián Spain 9 47 0.2× 452 2.1× 101 0.7× 80 0.6× 239 2.1× 9 865
J.A. Schifferli Switzerland 12 81 0.3× 465 2.2× 215 1.5× 44 0.3× 137 1.2× 30 746
Tariq El‐Shanawany United Kingdom 17 72 0.2× 467 2.2× 72 0.5× 71 0.5× 91 0.8× 29 890
Diana S. Beardsley United States 17 64 0.2× 167 0.8× 877 6.0× 148 1.0× 106 0.9× 30 1.3k
Friederike Mackensen Germany 22 145 0.5× 94 0.4× 193 1.3× 163 1.1× 198 1.7× 68 1.7k

Countries citing papers authored by Leslie Garrison

Since Specialization
Citations

This map shows the geographic impact of Leslie Garrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Garrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Garrison more than expected).

Fields of papers citing papers by Leslie Garrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Garrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Garrison. The network helps show where Leslie Garrison may publish in the future.

Co-authorship network of co-authors of Leslie Garrison

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Garrison. A scholar is included among the top collaborators of Leslie Garrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Garrison. Leslie Garrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borish, Larry, Harold S. Nelson, Miguel J. Lanz, et al.. (1999). Interleukin-4 Receptor in Moderate Atopic Asthma: A Phase I/II Randomized, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine. 160(6). 1816–1823. 322 indexed citations
2.
Garrison, Leslie, et al.. (1999). Etanercept: therapeutic use in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 58. I65–I69. 85 indexed citations
3.
Jones, Stephen E., Pankaj Khandelwal, Kristi McIntyre, et al.. (1999). Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Hematopoietic Growth Factor PIXY321 After Moderate-Dose Fluorouracil, Doxorubicin, and Cyclophosphamide in Stage II and III Breast Cancer. Journal of Clinical Oncology. 17(10). 3025–3032. 6 indexed citations
4.
5.
Rosenthal, Mark, David T. Dennis, Leonard Liebes, et al.. (1998). Biologic Activity of Interleukin 1 (IL-1) Alpha in Patients with Refractory Malignancies. Journal of Immunotherapy. 21(5). 371–378. 4 indexed citations
6.
Furman, Wayne L., Xiaolong Luo, Neyssa Marina, et al.. (1998). Comparison of Cytokines in Children with Recurrent Solid Tumors Treated with Intensive Chemotherapy. Journal of Pediatric Hematology/Oncology. 20(1). 62–68. 4 indexed citations
7.
Cairo, Mitchell S., Mark Krailo, Joel Weinthal, et al.. (1998). A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: a report of the Children's Cancer Group.. PubMed. 83(7). 1449–60. 10 indexed citations
8.
Furman, Wayne L., Xiaolong Luo, Diane Fairclough, et al.. (1997). Phase I trial of subcutaneous interleukin-1α in children with malignant solid tumors. Medical and Pediatric Oncology. 28(6). 444–450. 5 indexed citations
9.
Furman, Wayne L., John H. Rodman, Margaret Tonda, et al.. (1997). Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapy. Cancer Chemotherapy and Pharmacology. 41(3). 229–236. 1 indexed citations
10.
Bishop, Michael R., John D. Jackson, Kim Schmit-Pokorny, et al.. (1996). Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.. Journal of Clinical Oncology. 14(9). 2521–2526. 17 indexed citations
11.
Vose, J. M., J Anderson, P. J. Bierman, et al.. (1996). Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy.. Journal of Clinical Oncology. 14(2). 520–526. 9 indexed citations
12.
Runowicz, Carolyn D., John Mandeli, James L. Speyer, et al.. (1996). Phase I/II study of PIXY321 in combination with cyclophosphamide and carboplatin in the treatment of ovarian cancer. American Journal of Obstetrics and Gynecology. 174(4). 1151–1160. 11 indexed citations
13.
Jd, Bitran, et al.. (1996). A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells.. PubMed. 24(7). 823–8. 5 indexed citations
14.
Vadhan‐Raj, Saroj, et al.. (1994). Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer.. Journal of Clinical Oncology. 12(4). 707–714. 31 indexed citations
15.
Weisdorf, Daniel, Emmanuel Katsanis, Catherine M. Verfaillie, et al.. (1994). Interleukin-1 alpha administered after autologous transplantation: a phase I/II clinical trial. Blood. 84(6). 2044–2049. 28 indexed citations
16.
Vose, JM, Anne Kessinger, PJ Bierman, et al.. (1992). The use of rhIL-3 for mobilization of peripheral blood The International Journal of Cell Cloning in previously treated patients with lymphoid malignancies. Stem Cells. 10(S1). 62–64. 17 indexed citations
17.
18.
Viscidi, Raphael P., Edward F. Ellerbeck, Leslie Garrison, et al.. (1990). Characterization of Serum Antibody Responses to Recombinant HIV-1 gp160 Vaccine by Enzyme Immunoassay. AIDS Research and Human Retroviruses. 6(11). 1251–1256. 15 indexed citations
19.
Midthun, K, Leslie Garrison, M L Clements, et al.. (1990). Frequency of Indeterminate Western Blot Tests in Healthy Adults at Low Risk for Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 162(6). 1379–1382. 42 indexed citations
20.
Garrison, Leslie, et al.. (1989). Development of new vaccines for AIDS.. PubMed. 15(7). 47–55. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. E. G. Kr. v. d. Borne Breakdown of academic impact, for papers by Michael E. Osband Breakdown of academic impact, for papers by Maurizio Caniglia Breakdown of academic impact, for papers by Åke Jakobson Breakdown of academic impact, for papers by Schwartz Rs Breakdown of academic impact, for papers by Marta Cebrián Breakdown of academic impact, for papers by J.A. Schifferli Breakdown of academic impact, for papers by Tariq El‐Shanawany Breakdown of academic impact, for papers by Diana S. Beardsley Breakdown of academic impact, for papers by Friederike Mackensen
Rankless by CCL
2026